• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Immunosuppressive treatment strategy in connective tissue diseases].

作者信息

Okada J, Kondo H

机构信息

Kitasato University School of Medicine, Department of Internal Medicine.

出版信息

Nihon Rinsho. 1999 Feb;57(2):432-8.

PMID:10078019
Abstract

In this review, we summarized important articles published about immunosuppressive agents in connective tissue diseases. Intravenous cyclophosphamide therapy for lupus nephritis and oral cyclophosphamide therapy for Wegener's granulomatosis are major progress in past one decade. Newer immunosuppressive agents such as cyclosporin, tacrorimus are also introduced in steroid refractory organ involvements. And we discussed also the monitoring and prevention of adverse effects of immunosuppressive agents. This review will focus on immunosuppressive treatment strategy of connective tissue diseases.

摘要

相似文献

1
[Immunosuppressive treatment strategy in connective tissue diseases].
Nihon Rinsho. 1999 Feb;57(2):432-8.
2
Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide.重症结缔组织病的免疫抑制治疗：低剂量静脉注射环磷酰胺的疗效
Ann Rheum Dis. 1997 Aug;56(8):481-7. doi: 10.1136/ard.56.8.481.
3
Immunosuppressive agents in dermatology.皮肤科中的免疫抑制剂。
Dermatol Clin. 1993 Jan;11(1):73-85.
4
Treatment strategies and outcome of induction-refractory Wegener's granulomatosis or microscopic polyangiitis: analysis of 32 patients with first-line induction-refractory disease in the WEGENT trial.诱导缓解失败的韦格纳肉芽肿或显微镜下多血管炎的治疗策略和结局：WEGENT 试验中一线诱导缓解失败的 32 例患者的分析。
Ann Rheum Dis. 2010 Dec;69(12):2125-30. doi: 10.1136/ard.2010.131953. Epub 2010 Jul 19.
5
Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.韦格纳肉芽肿病中的膀胱癌：风险及与环磷酰胺的关系。
Ann Rheum Dis. 2004 Oct;63(10):1307-11. doi: 10.1136/ard.2003.019125. Epub 2004 May 6.
6
[Recent advances in diagnosis and treatment of connective tissue diseases].[结缔组织疾病诊断与治疗的最新进展]
Dtsch Med Wochenschr. 2011 Apr;136(14):710-2. doi: 10.1055/s-0031-1274570. Epub 2011 Mar 29.
7
Gonadal failure with cyclophosphamide therapy for lupus nephritis: advances in fertility preservation.狼疮性肾炎环磷酰胺治疗致性腺功能衰竭：生育力保存的进展。
Rheum Dis Clin North Am. 2010 Feb;36(1):99-108, viii. doi: 10.1016/j.rdc.2009.12.010.
8
[Treatment of systemic diseases with pulse cyclophosphamide: 15 cases].
Ann Med Interne (Paris). 1990;141(5):416-20.
9
[How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].[韦格纳肉芽肿病的环磷酰胺治疗应持续多长时间？]
Dtsch Med Wochenschr. 2002 Sep 13;127(37):1909-10. doi: 10.1055/s-2002-34063.
10
The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.静脉脉冲环磷酰胺治疗儿童重症狼疮性肾炎的疗效
J Med Assoc Thai. 1999 Nov;82 Suppl 1:S104-10.